# Regeneron Pharmaceuticals, Inc. (REGN): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Regeneron Pharmaceuticals, Inc. (REGN) is 93/100, ranked against 25,000+ stocks in 38 markets (Quality 71, Value 45, Momentum 83, each scored against its sector).

- MoatMap Score: 93/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 71, Value 45, Momentum 83: each a 0-100 percentile within Healthcare.
- Position: #1,909 overall, #209 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 951.19 USD on 12 Nov 2026.
- Insider filings, last 180 days: directors sold USD 52.4M.
- Buybacks, last 180 days: the company bought back USD 3.3B on 2 days.

Source: https://moatmap.ai/stock/REGN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker